Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary biliary cirrhosis.

R Moreno-Otero1, M Lisker-Melman, E A Jones

  • 1Liver Diseases Section, National Institute of Diabetes, and Digestive and Kidney Diseases, Bethesda, Maryland.

The Medical Clinics of North America
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increases in the enzyme activity of mouse mammary explants induced by prolactin.

The Journal of endocrinology·2025
Same author

The role of receptor MAS in microglia-driven retinal vascular development.

Angiogenesis·2019
Same author

Genotype-phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis.

The British journal of dermatology·2019
Same author

Mesoderm induction in the future tail region of Xenopus.

Roux's archives of developmental biology : the official organ of the EDBO·2017
Same author

Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection.

Genes and immunity·2015
Same author

Mesenchymal stem cells, autoimmunity and rheumatoid arthritis.

QJM : monthly journal of the Association of Physicians·2014
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Primary biliary cirrhosis (PBC) is an autoimmune liver disease causing bile duct inflammation. Current treatments manage complications, as no drug has proven effective, but research seeks immunosuppression to avoid liver transplants.

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease.
  • It is characterized by progressive intrahepatic cholestasis and inflammation of small bile ducts.
  • The etiology of PBC remains largely unknown.

Purpose of the Study:

  • To review the current understanding of Primary Biliary Cirrhosis (PBC).
  • To discuss the clinical presentation, diagnosis, and immunological aspects of PBC.
  • To evaluate existing and potential therapeutic strategies for PBC.

Main Methods:

  • Literature review of Primary Biliary Cirrhosis (PBC).
  • Analysis of clinical manifestations, diagnostic markers (serum alkaline phosphatase, mitochondrial antibodies, IgM), and associated immunologic abnormalities.

Related Experiment Videos

  • Assessment of current treatment approaches and future therapeutic directions.

    • Main Results:

    • PBC typically affects middle-aged women, presenting with symptoms like pruritus and jaundice.
    • Diagnostic hallmarks include elevated serum alkaline phosphatase, positive antimitochondrial antibodies (>90%), and elevated IgM.
    • PBC is strongly associated with autoimmune conditions, with defects in T-cell suppressor function implicated in pathogenesis.

    Conclusions:

    • Current treatments for PBC focus on managing complications of cholestasis, as no drug has demonstrated efficacy in halting disease progression.
    • Immunosuppressive therapy is a potential avenue, but its role requires further investigation.
    • Liver transplantation is a viable option for patients with advanced disease, but the ultimate goal is to develop effective immunosuppression to obviate the need for transplantation.